VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $54,579,000 | -12.6% | 305,968 | +8.8% | 1.79% | -13.2% |
| Q2 2015 | $62,453,000 | -27.5% | 281,128 | -35.2% | 2.06% | -35.2% |
| Q1 2015 | $86,177,000 | -27.7% | 433,880 | -47.9% | 3.18% | -26.6% |
| Q4 2014 | $119,177,000 | -4.9% | 832,762 | -12.8% | 4.33% | -0.1% |
| Q3 2014 | $125,355,000 | +5.1% | 955,449 | +1.0% | 4.33% | +6.1% |
| Q2 2014 | $119,306,000 | +73.4% | 945,972 | +81.2% | 4.08% | +82.1% |
| Q1 2014 | $68,808,000 | – | 521,945 | – | 2.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,586,582 | $864,160,000 | 32.02% |
| FARLEY CAPITAL L.P. | 341,518 | $44,807,000 | 30.12% |
| LeVasseur Capital Partners LLC | 190,404 | $24,981,000 | 29.94% |
| Ruane, Cunniff & Goldfarb | 34,494,015 | $4,525,615,000 | 23.97% |
| ValueAct Holdings | 18,923,877 | $2,482,813,000 | 16.64% |
| White River Investment Partners, LLC | 90,099 | $11,820,000 | 16.35% |
| Tesuji Partners | 1,368,040 | $179,487,000 | 15.45% |
| Arrow Capital Management, LLC | 197,500 | $25,912,000 | 15.11% |
| Hound Partners | 3,576,998 | $469,302,000 | 14.87% |
| Brahman Capital Corp. | 4,457,153 | $584,778,000 | 12.82% |